{"name":"Japan Blood Products Organization","slug":"japan-blood-products-organization","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"GB-0998","genericName":"GB-0998","slug":"gb-0998","indication":"Hereditary angioedema (HAE) prophylaxis","status":"phase_3"},{"name":"Placebo of GB-0998","genericName":"Placebo of GB-0998","slug":"placebo-of-gb-0998","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"GB-0998","genericName":"GB-0998","slug":"gb-0998","phase":"phase_3","mechanism":"GB-0998 is a recombinant human C1-inhibitor that regulates complement and contact system activation to prevent hereditary angioedema attacks.","indications":["Hereditary angioedema (HAE) prophylaxis"],"catalyst":""},{"name":"Placebo of GB-0998","genericName":"Placebo of GB-0998","slug":"placebo-of-gb-0998","phase":"phase_3","mechanism":"A placebo control arm in a clinical trial for GB-0998, containing no active pharmaceutical ingredient.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQNE9rb0hlUG9RLVNiR3NmVHdJajRMc09SR01Zekxaa1RfQ3pmTm5HMVkzTVdGVkNpMFFCQjNmdU1LYjF5NEp4Q3pyVHlQMjRfZkpKSGlacEIwUkpiLVh6S0dWME5hTFRnVEh3WEl3ZFN5a1BPTy1OMGprR08yc3E4VWlzM1RMUU5lSGRUb0QtWjJzd3NiMEg5NkxaUEtjck5kYmwyeA?oc=5","date":"2026-04-02","type":"regulatory","source":"IndexBox","summary":"Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo Drug - News and Statistics - IndexBox","headline":"Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo Drug - News and Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQTVZ0SElhOHd2b1habjFLdXF0Tm1UeUhPUlRmSmJ5QWJVa2wwZlNSNEFsZHhqVzZNOUxNcm83bnZCRFdOWmtKS1dBQjJuT3NCZ1BodEZieTBuSzlYbHhVVFVGMmRmT0U5YVNIV2lKcHB6YXZ0dEozMm9YMng3cU9ERjNtVEN0WEc4c3N4OGtoa3o3ZnhBSDNvSUl3Tkw5bllsOXVGYklMaVN2ZTJvbFdjZlUwVGtGTGstWmsyZFlvMy1BWW1oRWowdTBiNk1lWTBZQUNtX3JFbTdsb0x6dlE?oc=5","date":"2026-01-19","type":"pipeline","source":"Cureus","summary":"Compound Heterozygous Protein C Deficiency Presenting With Splenic Infarction After COVID-19: A Case Report - Cureus","headline":"Compound Heterozygous Protein C Deficiency Presenting With Splenic Infarction After COVID-19: A Case Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1GRGdpR3VZcnBfV2xWSVpYMUtMUlpKWXRZdXEyWGd5WGtWcEN3QVJoVlRleTZyUXpNaUhINmt0ZzVFNm04VHJQVXZobVdVRDJVQ1EtVTJOdDFkUGFkU2NR?oc=5","date":"2025-12-02","type":"trial","source":"nature.com","summary":"Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study - nature.com","headline":"Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFA5amZoenhjNnYtUjdWRHVTb1FsRWJabHhzd21Yall5djA1MFh4eUpaX1huZ3JWX09HTkZ3T3ZLakE3eUpRb1Fpd21Yd20xeHc4cmRqcmdhTWNTS2ttMndHY1pFMlZFT2lp?oc=5","date":"2025-07-13","type":"pipeline","source":"World Socialist Web Site","summary":"Trump’s tariff war threatens Australia’s Pharmaceutical Benefits Scheme and copper exports - World Socialist Web Site","headline":"Trump’s tariff war threatens Australia’s Pharmaceutical Benefits Scheme and copper exports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQemZqUmpCUVAzaXYxT2ozWXdNRlZYaFNQcGZpRHZIb3BOYXRFOFJQNy1Id2RlcURfRlBEempQM1ZmSE1DRllFWDZDT2JtanI0NHpxU1JLdmlsLXVWSGNpOWlnaUY5RDJDSEU1NDNNbktxbF9Tb250NEZ3bnFfVTZaWUZXS0tCMG5Jc1dpNmM0bnV6ZHk5WE9oSw?oc=5","date":"2025-05-05","type":"regulatory","source":"Yahoo Finance","summary":"Intravenous Immunoglobulin (IVIG) Market Forecast to Surge During the Forecast Period (2025-2034) with Rising Demand for Autoimmune and Immunodeficiency Treatments | DelveInsight - Yahoo Finance","headline":"Intravenous Immunoglobulin (IVIG) Market Forecast to Surge During the Forecast Period (2025-2034) with Rising Demand for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE16Sm5pRWRrQTdFWjQ3bDVMbVlCRkdsOXJITHk4bl9MMXFmQ0VqalgwY05ZVkR5c0NzSW1kUEx1WGVkZ1NtLVNUYk94WHdCc09XWW15aEp0dTBhN21KcEhB?oc=5","date":"2025-04-25","type":"pipeline","source":"nature.com","summary":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma - nature.com","headline":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRkdnVV9WRW1QRTA0UURzdUxmM1lTaEdGSVRZQ0UtbTg0dS01bVN4blFPaU9TWXEzdDdiWlo1a1hIT1Y0Z1dlSDRjcmtLYTJHdW81bE40SHpuNjZHT2NoQUQxNHQ2RklwUDIteFdrRVViWDZFNUw2WHRrZHpDaDRiUkRLRFhTdkNqV1RScmo2cVAzMHJIcVktdmh30gGfAUFVX3lxTE1CekVac0FGblZCX2FNLTFsSVFsVDRNeHBKcXliZHdwUzA1TzhUQzA0ZDdIS1UwMmhoeGRSVUdCR3BxbkMyaEN1dEI1OUVpLUJ2VG9JWUx6MGRZeGpsQ0c3SWR2MUlnOXNOcW5yVkNCREdyRU02M0xCMTFnVzVyZGg2NGR1MTc1Y1FBdG5DUWZzaVRnRmU0UWJXelY0c2dTVQ?oc=5","date":"2025-03-08","type":"pipeline","source":"Al Jazeera","summary":"How close are scientists to producing artificial blood? - Al Jazeera","headline":"How close are scientists to producing artificial blood?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5zZUd3ZGJ2NHZzQXFYV2ZpYV84UmFIR0Z6czdsS3VSV1F1akQ2TTJ1dklOM3k5dC0weFl1ZXZ0MjJfWDFVWEdELVhNR190VkVTdTlEV1ZndFFPeGdXYnhRX05UTzd2NHU5WGY2Tg?oc=5","date":"2024-10-30","type":"pipeline","source":"American Heart Association Journals","summary":"Effects of Haptoglobin on Early Brain Injury, Vasospasm, and Lymphatic Drainage After Subarachnoid Hemorrhage in Mice - American Heart Association Journals","headline":"Effects of Haptoglobin on Early Brain Injury, Vasospasm, and Lymphatic Drainage After Subarachnoid Hemorrhage in Mice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNbFhKT0RxN3ZnUzNqaUN0VkZ3Z0tCYkZKY1hycmdhUVd0OHVOYWVvT2Z5ajVVNUxJU1FucW9EbEJISVZLemxfQWdwSlVCbDhnUDJfNGVUczV0TXRJdGpsMllNR3F0RmtjWlk1S1VPY3BxcDVCSWIzdUw1QW1GUGMxSGxJLVBwUFp1LVBoRkpQWUxlaWU2aVA4SzFMSFZGYWxhaE1lVEhHTHU3TV9KWWRabGh6alphUkJVeS1DT284LTFZSzVv?oc=5","date":"2023-09-05","type":"pipeline","source":"World Health Organization (WHO)","summary":"Ensuring availability and safety of blood and blood products in Indonesia - World Health Organization (WHO)","headline":"Ensuring availability and safety of blood and blood products in Indonesia - World Health Organization (WHO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOMzM4Um1mN3ViNFZ0c283SU8wbjhGMHVjWDVUR0gwOW85azUzLUk4MEdYeEhmOUJSSENDQXJVaG1SeG1XTDV4cDV5bnkwcVlrVGh1ekZqcG1RelBiS1IyLWM0YTRORUJlSUZKRWJwUlZ6SnprVFdRYjlQRGJKcU9ZRjdVMk9pUTlxRmowUGhCd2tCQQ?oc=5","date":"2023-07-31","type":"earnings","source":"Yahoo Finance","summary":"Plasma Fractionation Market revenue to exceed USD 37 Billion by 2033, says Research Nester - Yahoo Finance","headline":"Plasma Fractionation Market revenue to exceed USD 37 Billion by 2033, says Research Nester","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE0tVkpXRWdWcEVFXzZvY2Q1VVNzcDFhMmVlT3ZZT0dIX0I3ZVBiS005czJYNU56OWFFaDZUSGstQjZrNDJaazVhOV8tSk9rWk8wZmR1c2IzZXZjeFNDX3p0MTRrQmk4bFJna1V5WGdxT1c2Zw?oc=5","date":"2022-12-20","type":"trial","source":"Wiley Online Library","summary":"Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study - Wiley Online Library","headline":"Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5QMkNXQzNmSTBpTXd6WDR4MFZEbENjUXNmSHM1WUxhNkZRd0YxYktyUTRPaDJsNXgteXNqR3ZYRjN4WnpYc1Q4S1JLNmRnVWZMZ3U3VmktWjRaak84bGFEQ2JqdFQ1cXNhemc?oc=5","date":"2021-12-21","type":"trial","source":"Wiley Online Library","summary":"Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes - Wiley Online Library","headline":"Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}